Infectious diseases

Chinese Construction Market Outlook to 2024 - China is Expected to Spend US$1.4 Trillion on New Infrastructure Projects Between 2020 and 2025

Contemporary history, Health, COVID-19 pandemic, Occupational safety and health, Pandemics, Public Health Emergency of International Concern, Infectious diseases
Thursday, January 21, 2021 - 6:15pm

The Chinese construction industry has already recovered from the disruption caused by the COVID-19 pandemic.

Key Points: 
  • The Chinese construction industry has already recovered from the disruption caused by the COVID-19 pandemic.
  • With the gradual resumption of construction activities, the industry has regained growth momentum, and is expected to expand in 2020 as a whole.
  • According to the government-backed think tank, the China Electronic Information Industry Development (CCID), the country is expected to spend CNY10 trillion (US$1.4 trillion) on new infrastructure projects between 2020-2025.
  • It provides -
    Historical (2015-2019) and forecast (2020-2024) valuations of the construction industry in China, featuring details of key growth drivers.

Statement from the Chief Public Health Officer of Canada on January 21, 2021

Coronavirus disease, Occupational safety and health, Zoonoses, Health, Infectious diseases, Medical specialties, Prevention, Epidemiology
Thursday, January 21, 2021 - 5:00pm

Though many areas continue to experience high infection rates, it is important to remember that the vast majority of Canadians remain susceptible to COVID-19.

Key Points: 
  • Though many areas continue to experience high infection rates, it is important to remember that the vast majority of Canadians remain susceptible to COVID-19.
  • This is why it is important for everyone to continue with individual precautions to protect ourselves, our families and our communities.
  • Strong and sustained efforts are needed to reduce heavy demands on the healthcare system and health workforce.
  • Canada needs a collective effort, from public health authorities and individuals, as a range of public health measures and restrictions are implemented to interrupt rapid spread of the virus.

COVID-19 Impacts and Recovery | Global Hepatitis C Drugs Market Research During 2021-2025 | Technavio

Infectious diseases, Pharmaceutical, Health, Hepatitis
Thursday, January 21, 2021 - 4:50pm

View the full release here: https://www.businesswire.com/news/home/20210121005731/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210121005731/en/
    Technavio has announced its latest market research report titled Global Hepatitis C Drugs Market 2021-2025 (Graphic: Business Wire).
  • The report on the hepatitis C drugs market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The hepatitis C drugs market analysis includes the product and geography landscape.
  • The hepatitis C drugs market covers the following areas:

The Vistria Group and Excellere Partners Invest in SCA Pharmaceuticals

Medical Supplies, Infectious diseases, Hospitals, Finance, FDA, Professional services, Cardiology, Biotechnology, Pharmaceutical, Health, SCA, Pharmaceutical industry in China
Thursday, January 21, 2021 - 4:59pm

The Vistria Group and Excellere Partners have purchased all of the issued and outstanding equity interests of SCA Pharma.

Key Points: 
  • The Vistria Group and Excellere Partners have purchased all of the issued and outstanding equity interests of SCA Pharma.
  • We are very pleased that as we continue our expansion efforts and improvements in our efficiencies, our new partnership with The Vistria Group and Excellere will allow us to accelerate these efforts, said Milton Boyer, CEO of SCA Pharma.
  • We look forward to working with Excellere to take the high standards set by SCA even further, said Jon Maschmeyer, Partner at Vistria.
  • An emerging national leader in compounded pharmaceuticals, SCA Pharma previously was wholly owned by Enhanced Healthcare Partners.

Graco Launches Highest-Powered Electrostatic Airless Disinfectant Sprayer

Infectious diseases, Chemicals, Plastics, Health, Manufacturing, Childhood, Agricultural machinery, Sprayer, Graco, Spray, Electrostatics, Human development, Ageing
Thursday, January 21, 2021 - 4:29pm

Graco Inc. (NYSE:GGG), a leading manufacturer of fluid handling equipment, is proud to introduce the new SaniSpray HPTM 20 Cordless Electrostatic Airless ProPack System that includes the most powerful airless and electrostatic spraying capabilities for the ultimate flexibility and portability to quickly handle every disinfecting job.

Key Points: 
  • Graco Inc. (NYSE:GGG), a leading manufacturer of fluid handling equipment, is proud to introduce the new SaniSpray HPTM 20 Cordless Electrostatic Airless ProPack System that includes the most powerful airless and electrostatic spraying capabilities for the ultimate flexibility and portability to quickly handle every disinfecting job.
  • Graco has responded to increased disinfecting protocols by incorporating its industry-leading airless and electrostatic technologies into a revolutionary new solution that provides front line workers with a faster way to disinfect spaces and complex surfaces.
  • The SaniSpray HP 20 electrostatic sprayer is a game changer because it is the fastest tool to apply chemicals with superior wrapping power for complete coverage, said Dan Johnson, Global Total Markets Manager at Graco.
  • The SaniSpray HP 20 Cordless Electrostatic Airless ProPack is the only portable disinfecting system with three powerful technologies in one system.

Ian Khan & Futuracy Films presents New Documentary, GX Now, Reveals Future Ready Government Service Models

Other Health, General Health, Entertainment, Film & Motion Pictures, Data management, Technology, Infectious diseases, General Entertainment, Other Government, Other Entertainment, Other Technology, Health, Public policy, Government, Public administration, E-government, Politics and technology
Thursday, January 21, 2021 - 4:00pm

GX Now, a new documentary film, presented by Futurist Ian Khan, on how governments globally are changing service delivery models and adapting to technology, while creating a better citizen experience, is releasing worldwide on Jan 21, 2021.

Key Points: 
  • GX Now, a new documentary film, presented by Futurist Ian Khan, on how governments globally are changing service delivery models and adapting to technology, while creating a better citizen experience, is releasing worldwide on Jan 21, 2021.
  • GX Now covers the evolution of public services, and tracks the governments of UAE, Estonia, Netherlands and, Azerbaijan in to find answers on why Experiences may be the key to unlocking the value behind government-citizen engagements.
  • Today governments services are rapidly changing & it becomes necessary to document this and help other governments across the world learn from what early adopters are doing, said Ian Khan.
  • Governments should collect, analyze, and implement data wisely in order to become more competitive and resilient".

Rite Aid Expands No-Charge COVID-19 Testing to 460 Drive-Through Locations

Other Consumer, Discount, Variety, Infectious diseases, Convenience store, Other Health, Health, Consumer, Pharmaceutical, Retail, Rite Aid, COVID-19 testing, Medicine, Health care, Companies
Thursday, January 21, 2021 - 3:00pm

The new locations will increase Rite Aid's capacity for COVID-19 testing services in California, Washington, Michigan, Ohio, Pennsylvania, Virginia, New York, Massachusetts, New Jersey and Maryland.

Key Points: 
  • The new locations will increase Rite Aid's capacity for COVID-19 testing services in California, Washington, Michigan, Ohio, Pennsylvania, Virginia, New York, Massachusetts, New Jersey and Maryland.
  • At all testing locations, patients are required to pre-register online at www.riteaid.com in order to schedule a time slot for testing.
  • Rite Aid partners with Verily and its Baseline COVID-19 Testing Program to provide screening, scheduling and return of results to participants for Rite Aid testing sites.
  • Rite Aid will continue to provide regular updates on the company's progress with COVID-19 testing.

Beacon Health Options Provides Needed Relief for Those Caught in Twin Pandemics of Opioid Use Disorder and COVID-19

Mental health, MEN, Managed care, Professional services, Infectious diseases, Gay & Lesbian, Hospitals, Family, Consumer, Health, Other Health, Other Consumer, Insurance, Teens, Women, Parenting, Pharmaceutical, Opioid use disorder, Substance dependence, Beacon Health Options, Opioid, Opioid epidemic in the United States
Thursday, January 21, 2021 - 2:50pm

The crisis of increasing opioid use disorder (OUD) shows no sign of abating in Massachusetts.

Key Points: 
  • The crisis of increasing opioid use disorder (OUD) shows no sign of abating in Massachusetts.
  • Clearly, more needs to be done to save lives that are being taken prematurely by opioid use disorder.
  • In late 2019, to help address this ongoing crisis in Massachusetts, Beacon Health Options, a leading behavioral health services company headquartered in Boston, announced the distribution of $128,800 in grants to four community-based behavioral health organizations.
  • Beacon Health Options is a leading behavioral health services company serving 1 out of 9 people across all 50 states.

PWNHealth Introduces New Patient Support Program to Bolster National COVID-19 Vaccination Rollout

General Health, Infectious diseases, Health, Science, Other Science, Vaccination, Medical specialties, Biotechnology, Vaccine, Life sciences, Medicine, Vaccination policy
Thursday, January 21, 2021 - 2:37pm

This month, PWN began rolling out its COVID-19 vaccination support program in collaboration with CIC Health, a Cambridge, Mass.-based health tech company offering COVID-19 testing and vaccination services.

Key Points: 
  • This month, PWN began rolling out its COVID-19 vaccination support program in collaboration with CIC Health, a Cambridge, Mass.-based health tech company offering COVID-19 testing and vaccination services.
  • CIC Health has been selected by the Commonwealth of Massachusetts to operate New England's first mass vaccination site at Gillette Stadium in Foxborough.
  • PWNs COVID-19 vaccination support program is now available nationwide.
  • PWN's vaccination program will incorporate CDC-supported technologies to empower personalized check-ins and streamline side effect reporting with recipients.

Moderna Announces First Participant Dosed in Phase 1/2 Study of Moderna COVID-19 Vaccine in Japan Led by Takeda

Biotechnology, Infectious diseases, Other Health, Health, Pharmaceutical, Medicine, Medical research, Health sciences, Articles, Clinical trials, COVID-19 vaccine, MRNA-1273, Moderna, Vaccine, Tozinameran, RNA vaccine
Thursday, January 21, 2021 - 2:00pm

(Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participant has been dosed in the Phase 1/2 study of Modernas vaccine candidate against COVID-19 (mRNA-1273 or TAK-919) in Japan, led by Takeda Pharmaceutical Co., Ltd (NYSE: TAK).

Key Points: 
  • (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participant has been dosed in the Phase 1/2 study of Modernas vaccine candidate against COVID-19 (mRNA-1273 or TAK-919) in Japan, led by Takeda Pharmaceutical Co., Ltd (NYSE: TAK).
  • We are pleased that this Phase 1/2 study of our COVID-19 vaccine in healthy adults in Japan has begun.
  • This placebo-controlled Phase 1/2 study will evaluate the safety and immunogenicity of two vaccinations of mRNA-1273 given 28 days apart.
  • Takeda and Moderna previously announced that Takeda will import and distribute 50 million doses of Modernas COVID-19 vaccine candidate starting in the first half of 2021, pending licensure in Japan.